UPDATE : Monday, September 7, 2020
상단여백
Analyst warns of possible ‘bubble’ amid bio-share surge by Lee Han-soo 2018-01-23 15:15
Shares of ‘Celltrion trio’ plummet on profit-taking by Nam Doo-hyun 2018-01-18 11:10
Shares of eye drops/masks makers rise on fine dust measure by Nam Doo-hyun 2018-01-15 15:48
Luxturna to open gene therapies market: analyst by Nam Doo-hyun 2018-01-10 15:48
Bio-shares on the rise by Lee Han-soo 2018-01-09 15:26
라인
Celltrion’s market cap exceeds 36 trillion won by Lee Han-soo 2018-01-08 12:27
Drugmakers rush to attend JP Morgan’s healthcare event by So Jae-hyeon 2018-01-08 11:44
Celltrion stocks jump on expectations of rising market share by Lee Han-soo 2018-01-04 16:40
Venture capital investment in biomedical sector drops 20% in 2017 by Nam Doo-hyun 2018-01-04 09:30
Samyang Biopharm wins patent suit against Helsinn Healthcare by Lee Han-soo 2018-01-03 16:58
라인
70% of biotech firms enjoy stock price gains in 2017 by Nam Doo-hyun 2018-01-02 17:42
HanAll vice chairman sells off stake despite export deal by So Jae-hyeon 2018-01-02 13:57
Kolon Life Science’s shares plummet on drifting export deal by Nam Doo-hyun 2017-12-21 13:16
HanAll inks $30 million tech export deal by So Jae-hyeon 2017-12-20 15:49
₩500-billion Invossa technology export to Japan in peril by Nam Doo-hyun 2017-12-20 14:59
라인
FDA to review Samsung Bioepis’ trastuzumab biosimilar by Lee Han-soo 2017-12-20 14:37
Nature Cell expects to receive conditional approval for Jointstem by Lee Han-soo 2017-12-19 18:22
‘Celltrion’s annual revenue to top ₩3 trillion in 5 years’ by Nam Doo-hyun 2017-12-18 15:55
Samsung Bioepis, Daewoong sign exclusive supply contract for Samfenet by Lee Han-soo 2017-12-18 10:59
Corestem’s NeuroNata-R marks increase in foreign patients by Lee Han-soo 2017-12-15 16:22
여백
여백
여백
Back to Top